When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMS - FDA accepts Adamas application for expanded use of Gocovri
Adamas Pharmaceuticals Inc.
The FDA accepts for review Adamas Pharmaceuticals' (NASDAQ:ADMS) supplemental marketing application seeking approval to use Gocovri (amantadine) to treat OFF episodes in Parkinson's disease (PD) patients receiving levodopa-based therapy. The agency's action date is February 1, 2021.
More news on: Adamas Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,